Skip to main content
logo
ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.480
0.00 (0.00%)
Apr 29, 2026, 12:53 PM EDT - Market open

ProQR Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
156213279160299571
Market Cap Growth
32.37%-23.84%74.16%-46.40%-47.60%150.93%
Enterprise Value
61.96115.4135.2248.87216.41418.27
Last Close Price
1.482.022.651.983.708.01
PE Ratio
--4.30-7.97-5.11-3.83-7.41
PS Ratio
7.9011.0913.7315.2263.96211.05
PB Ratio
2.693.673.033.504.164.41
P/TBV Ratio
3.164.312.583.873.954.51
P/FCF Ratio
--3.37-7.107.19-4.03-18.94
P/OCF Ratio
--3.43-7.376.73-4.07-19.29
EV/Sales Ratio
3.236.026.654.6446.28154.68
EV/EBITDA Ratio
--2.41-4.69-1.51-3.22-6.70
EV/EBIT Ratio
--2.26-4.26-1.39-3.10-6.43
EV/FCF Ratio
--1.83-3.442.19-2.91-13.88
Debt / Equity Ratio
0.190.190.120.440.270.48
Debt / EBITDA Ratio
-0.39-0.39-0.62-0.67-0.35-1.10
Debt / FCF Ratio
-0.30-0.30-0.450.98-0.32-2.28
Net Debt / Equity Ratio
-1.55-1.55-1.49-2.40-1.09-1.12
Net Debt / EBITDA Ratio
1.881.884.773.381.162.32
Net Debt / FCF Ratio
1.421.423.50-4.921.054.80
Asset Turnover
0.120.120.130.060.020.02
Quick Ratio
3.063.063.943.484.526.80
Current Ratio
3.093.093.953.547.366.94
Return on Equity (ROE)
-61.17%-61.17%-42.73%-51.33%-71.37%-71.62%
Return on Assets (ROA)
-30.97%-30.97%-19.79%-20.55%-34.26%-37.18%
Return on Invested Capital (ROIC)
-234.31%-234.31%-184.42%-69.98%-136.42%-264.91%
Return on Capital Employed (ROCE)
-41.50%-41.50%-26.19%-25.08%-39.22%-42.31%
Earnings Yield
-32.65%-23.26%-12.55%-19.55%-26.09%-13.49%
FCF Yield
-41.46%-29.69%-14.09%13.91%-24.82%-5.28%
Buyback Yield / Dilution
-22.36%-22.36%-6.26%-13.08%-11.62%-28.21%
Total Shareholder Return
-22.36%-22.36%-6.26%-13.08%-11.62%-28.21%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q